GE HealthCare Technologies (NASDAQ:GEHC) Issues Quarterly Earnings Results

GE HealthCare Technologies (NASDAQ:GEHC) announced its quarterly earnings data on Wednesday. The company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14, FiscalAI reports. The company had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the company posted $1.07 EPS.

Here are the key takeaways from GE HealthCare Technologies’ conference call:

• GE HealthCare raised its full-year 2026 guidance, now expecting approximately 4% organic revenue growth, 15.5%–15.7% adjusted EBIT margin, adjusted EPS of $4.95–$5.05, and free cash flow above $1.6 billion.
• Third-quarter results exceeded expectations, with organic revenue up 6.2%, adjusted EBIT margin expanding 180 basis points to 16.6%, adjusted EPS rising 25.1% to $1.34, and free cash flow increasing to $793 million.
• Pharmaceutical Diagnostics delivered 13.8% organic growth, while Flyrcado adoption continued to build; management remains confident in its goal of reaching a $500 million annualized Flyrcado revenue run rate exiting 2028. The planned SOFIE Biosciences acquisition is intended to strengthen U.S. radiopharmaceutical distribution, manufacturing control, and the precision-medicine pipeline.
• Patient Care Solutions improved sharply, with organic revenue up 8.8% and margin expanding 480 basis points, but fourth-quarter growth will be muted by a difficult comparison related to a prior-year product-hold release. PCS leadership is changing, and GE HealthCare is still evaluating strategic options for the business, although management said the review timeline is unaffected.
• Management characterized capital-equipment demand and the imaging pipeline as resilient, with backlog up 12% year over year to $23.7 billion, but acknowledged ongoing risks from tariffs, inflation, oil prices, and elevated memory-chip costs. Multi-year supplier agreements are expected to improve component availability and reduce supply-chain volatility into 2027.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC traded up $5.04 during trading hours on Wednesday, hitting $76.15. The stock had a trading volume of 4,215,109 shares, compared to its average volume of 4,213,773. The firm’s 50-day moving average price is $68.30 and its two-hundred day moving average price is $70.23. GE HealthCare Technologies has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a market capitalization of $34.40 billion, a P/E ratio of 17.50 and a beta of 0.73.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.67%.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported third-quarter adjusted earnings of $1.34 per share, above the $1.20-$1.21 analyst consensus and up from $1.07 a year earlier. Revenue rose 7.2% year over year to $5.51 billion, exceeding estimates of roughly $5.35 billion. GE HealthCare Technologies Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management cited strong top-line growth, margin expansion across all segments, disciplined operations and continued customer adoption of new products. Higher earnings and improved operating performance supported the increase in the company’s fiscal 2026 guidance. GE HealthCare Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Analysts highlighted broad segment growth and higher margins as the main drivers of the earnings beat, suggesting that strong imaging demand and GE HealthCare’s backlog are translating into improved profitability. GEHC Q3 Earnings Beat Estimates on Strong Growth, 2026 View Raised
• Neutral Sentiment: Jeannette Bankes, president and CEO of Patient Care Solutions, will leave GE HealthCare for a CEO position at another company. The leadership change could create a near-term transition issue, although no operational impact was announced. GE HealthCare Shares Rise on Higher Q3 Results and FY26 Outlook Upgrade
• Negative Sentiment: Before the results, investors were watching for inflation, supply-chain constraints and potential weakness in Patient Care Solutions to pressure margins. The quarter’s margin expansion and guidance increase appear to have reduced those concerns, but they remain risks to monitor. GEHC Ahead of Q3 Earnings

Analyst Ratings Changes

Several brokerages have recently commented on GEHC. UBS Group upped their target price on GE HealthCare Technologies from $67.00 to $73.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Barclays upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Wednesday, October 7th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. Wolfe Research initiated coverage on shares of GE HealthCare Technologies in a report on Tuesday, October 20th. They issued a “peer perform” rating for the company. Finally, Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $78.35.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.